Literature DB >> 11479426

Differential expression levels of Par-4 in melanoma.

T Lucas1, B Pratscher, S Krishnan, D Fink, P Günsberg, M Wolschek, V Wacheck, T Muster, I Romirer, K Wolff, H Pehamberger, H G Eichler, V M Rangnekar, B Jansen.   

Abstract

The pro-apoptotic prostate apoptosis response-4 gene product Par-4 sensitizes prostate cells to the induction of programmed cell death. In this study we examined Par-4 expression in human melanoma cell lines and melanoma metastases. The heterogeneous expression detected prompted us to investigate the biological relevance of Par-4 in a human melanoma xenotransplantation model. Overexpression of Par-4 by transfection decreased tumour development in xenotransplanted A375-C6 melanoma cells in SCID mice and correlated to an increase in tumour cell apoptosis. These data suggest that high expression of the pro-apoptotic protein Par-4 could qualify as a prognostic marker in human melanoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11479426     DOI: 10.1097/00008390-200108000-00008

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  6 in total

Review 1.  Cancer-selective apoptotic effects of extracellular and intracellular Par-4.

Authors:  T Shrestha-Bhattarai; V M Rangnekar
Journal:  Oncogene       Date:  2010-05-03       Impact factor: 9.867

2.  The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cells.

Authors:  Yinxing Liu; Misty R Gilbert; Natasha Kyprianou; Vivek M Rangnekar; Craig Horbinski
Journal:  Acta Neuropathol       Date:  2014-08-19       Impact factor: 17.088

3.  Par-4 is an essential downstream target of DAP-like kinase (Dlk) in Dlk/Par-4-mediated apoptosis.

Authors:  Meike Boosen; Susanne Vetterkind; Jan Kubicek; Karl-Heinz Scheidtmann; Susanne Illenberger; Ute Preuss
Journal:  Mol Biol Cell       Date:  2009-07-22       Impact factor: 4.138

4.  Simultaneous dual targeting of Par-4 and G6PD: a promising new approach in cancer therapy? Quintessence of a literature review on survival requirements of tumor cells.

Authors:  Ingeborg Elisabeth Cernaj
Journal:  Cancer Cell Int       Date:  2016-11-15       Impact factor: 5.722

5.  Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity.

Authors:  Simone Aparecida de Bessa Garcia; Ana Carolina Pavanelli; Natália Cruz E Melo; Maria Aparecida Nagai
Journal:  Int J Mol Med       Date:  2017-02-21       Impact factor: 4.101

6.  TRIM21 is a novel regulator of Par-4 in colon and pancreatic cancer cells.

Authors:  Jeffrey Q Nguyen; Rosalyn B Irby
Journal:  Cancer Biol Ther       Date:  2016-11-10       Impact factor: 4.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.